Dashboard
Manage Tickers

VANI


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-sunday-vivani-medical-prices-registered-direct-offering-of-6m-common-shares-and-concurrent-private-placement-of-3703703-shares-at-162-per-share
Reported Sunday, Vivani Medical Prices Reg...
10/27/2025 06:26:16

vivani-medical-will-temporarily-withdraw-record-date-for-planned-spin-off-of-cortigent-subsidiary-expects-to-announce-new-record-date-as-soon-as-possible
Vivani Medical Will Temporarily Withdraw R...
10/03/2025 12:32:08

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/17/2025 17:08:10

vivani-sets-october-8-record-date-for-spin-off-of-cortigent-to-trade-under-nasdaq-ticker-crgt
Vivani Sets October 8 Record Date For Spin...
09/17/2025 12:35:22

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only compan...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/17/2025 12:12:13

vivani-medical-plans-to-initiate-phase-1-clinical-study-in-npm-139-semaglutide-implant-program-in-first-half-of-2026-pending-regulatory-clearance
Vivani Medical Plans To Initiate Phase 1 C...
09/04/2025 12:36:15

NPM-139 has potential to provide Wegovy®-level efficacy with once or twice-yearly administrationFirst-in-human Phase 1 study is...

hc-wainwright--co-reiterates-buy-on-vivani-medical-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Viva...
09/02/2025 11:07:38

HC Wainwright & Co. analyst Yi Chen reiterates Vivani Medical (NASDAQ:VANI) with a Buy and maintains $4 price target.

vivani-medical-announces-it-will-spin-off-cortigent-as-independent-public-company
Vivani Medical Announces It Will Spin Off ...
08/13/2025 20:28:48

vivani-medical-q2-eps-012-misses-010-estimate
Vivani Medical Q2 EPS $(0.12) Misses $(0.1...
08/13/2025 20:22:03

Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0....

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

vivani-medical-announces-the-appointment-of-anthony-baldor-as-chief-financial-officer
Vivani Medical Announces The Appointment O...
06/11/2025 12:12:33

Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company deve...

hc-wainwright--co-reiterates-buy-on-vivani-medical-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Viva...
05/19/2025 11:33:17

HC Wainwright & Co. analyst Yi Chen reiterates Vivani Medical (NASDAQ:VANI) with a Buy and maintains $4 price target.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 21:06:18

vivani-medical-q1-eps-011-misses-010-estimate
Vivani Medical Q1 EPS $(0.11) Misses $(0.1...
05/13/2025 20:46:21

Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0....

hc-wainwright--co-reiterates-buy-on-vivani-medical-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Viva...
04/16/2025 11:42:51

HC Wainwright & Co. analyst Yi Chen reiterates Vivani Medical (NASDAQ:VANI) with a Buy and maintains $4 price target.

vivani-medical-expands-collaboration-with-okava-pharmaceuticals-to-include-dogs-in-development-of-okv-119-a-long-acting-glp-1-therapy-for-weight-management-diabetes-and-other-cardiometabolic-conditions
Vivani Medical Expands Collaboration With ...
04/15/2025 12:35:18

ALAMEDA, Calif. and SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or t...

hc-wainwright--co-reiterates-buy-on-vivani-medical-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Viva...
04/04/2025 11:06:04

HC Wainwright & Co. analyst Yi Chen reiterates Vivani Medical (NASDAQ:VANI) with a Buy and maintains $4 price target.

vivani-medical-q4-2024-gaap-eps-011-inline-as-of-december-31-2024-vivani-had-cash-cash-equivalents-and-restricted-cash-totaling-197m-additional-825m-equity-financing-which-secures-solid-financial-position-into-q2-of-2026
Vivani Medical Q4 2024 GAAP EPS $(0.11), I...
03/31/2025 11:36:23

Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a...

vivani-medical-plans-private-placement-of-737m-shares-at-112-per-share-expected-to-result-in-gross-proceeds-of-825m
Vivani Medical Plans Private Placement Of ...
03/27/2025 11:35:45

Financing strengthens balance sheet, extending expected runway into the second quarter of 2026. 

hc-wainwright--co-reiterates-buy-on-vivani-medical-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on Viva...
03/26/2025 15:48:28

HC Wainwright & Co. analyst Yi Chen reiterates Vivani Medical (NASDAQ:VANI) with a Buy and maintains $4 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION